ResearcherUniversity of MiyazakiActive in the last 2 years
Masahide Hiyoshi
Matched on ORCID iD 0000-0002-2392-7787; OpenAlex author ID A5004078883. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 3
- Recent changes in surgical outcomes and preoperative biliary drainage with the increased use of neoadjuvant chemotherapy in pancreatic cancer patients undergoi… Last author DOI 10.21037/gs-2024-507↗
- Integrin α6A (ITGA6A)-type Splice Variant in Extracellular Vesicles Has a Potential as a Novel Marker of the Early Recurrence of Pancreatic Cancer. Co-author DOI 10.21873/anticanres.15653↗
- A successful case of locally advanced pancreatic cancer undergoing curative distal pancreatectomy with en bloc celiac axis resection after combination chemothe… Co-author DOI 10.1007/s12328-017-0793-5↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Naoya İmamura · 3 shared papers, 2017–2025 · strength 0.52
- Paper Recent changes in surgical outcomes and preoperative biliary drainage with the increased use of neoadjuvant chemotherap… DOI 10.21037/gs-2024-507↗
- Paper Integrin α6A (ITGA6A)-type Splice Variant in Extracellular Vesicles Has a Potential as a Novel Marker of the Early Recu… DOI 10.21873/anticanres.15653↗
- Paper A successful case of locally advanced pancreatic cancer undergoing curative distal pancreatectomy with en bloc celiac a… DOI 10.1007/s12328-017-0793-5↗
- Yoshiro Fujii · 2 shared papers, 2017–2022 · strength 0.22
- Paper Integrin α6A (ITGA6A)-type Splice Variant in Extracellular Vesicles Has a Potential as a Novel Marker of the Early Recu… DOI 10.21873/anticanres.15653↗
- Paper A successful case of locally advanced pancreatic cancer undergoing curative distal pancreatectomy with en bloc celiac a… DOI 10.1007/s12328-017-0793-5↗
- Takashi Asada · 1 shared paper, 2022 · strength 0.15
- Kazuhiro Morishita · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.